Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-3.02%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$697M
Cap. Flow
% of AUM
2.02%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,345
Closed
332
Top Buys
| 1 |
Enphase Energy
ENPH
|
+$352M |
| 2 |
Intel
INTC
|
+$208M |
| 3 |
TSMC
TSM
|
+$196M |
| 4 |
Procter & Gamble
PG
|
+$158M |
| 5 |
Johnson & Johnson
JNJ
|
+$157M |
Top Sells
| 1 |
Netflix
NFLX
|
+$405M |
| 2 |
Occidental Petroleum
OXY
|
+$308M |
| 3 |
PayPal
PYPL
|
+$306M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$120M |
Sector Composition
| 1 | Technology | 26.64% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Neurogene
NGNE
$270M
| $252K | ﹤0.01% |
19,700
+320
| +2% | +$4.09K |
|
|
TECX
2127
Tectonic Therapeutic, Inc. Common Stock
TECX
$332M
| $252K | ﹤0.01% |
32,683
-14,650
| -31% | -$113K |
|
|
OPNT
2128
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $252K | ﹤0.01% |
23,400
-51,000
| -69% | -$549K |
|
2129
XBiotech
XBIT
$86.3M
| $251K | ﹤0.01% |
69,300
+37,500
| +118% | +$136K |
|
|
SLGC
2130
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $251K | ﹤0.01% |
86,700
+70,200
| +425% | +$203K |
|
2131
Biglari Holdings Class B
BH
$961M
| $250K | ﹤0.01% |
2,159
-2,200
| -50% | -$255K |
|
2132
BankFinancial
BFIN
$154M
| $249K | ﹤0.01% |
26,285
-5,600
| -18% | -$53K |
|
2133
LCNB Corp
LCNB
$226M
| $249K | ﹤0.01% |
15,700
-12,100
| -44% | -$192K |
|
2134
Lineage Cell Therapeutics
LCTX
$281M
| $249K | ﹤0.01% |
220,063
-43,003
| -16% | -$48.7K |
|
2135
Savara
SVRA
$674M
| $249K | ﹤0.01% |
160,415
-2,700
| -2% | -$4.19K |
|
|
PRSU
2136
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.02B
| $249K | ﹤0.01% |
7,900
-400
| -5% | -$12.6K |
|
2137
Paymentus
PAY
$4.4B
| $248K | ﹤0.01% |
+25,500
| New | +$248K |
|
2138
Alignment Healthcare
ALHC
$3.27B
| $247K | ﹤0.01% |
+20,900
| New | +$247K |
|
2139
HBT Financial
HBT
$809M
| $247K | ﹤0.01% |
13,600
-1,300
| -9% | -$23.6K |
|
2140
Mueller Industries
MLI
$10.7B
| $244K | ﹤0.01% |
+8,200
| New | +$244K |
|
|
VNTR
2141
DELISTED
Venator Materials PLC
VNTR
| $243K | ﹤0.01% |
276,200
-59,600
| -18% | -$52.4K |
|
2142
Patria Investments
PAX
$2.26B
| $241K | ﹤0.01% |
18,500
-400
| -2% | -$5.21K |
|
2143
Pitney Bowes
PBI
$1.94B
| $241K | ﹤0.01% |
103,500
-189,200
| -65% | -$441K |
|
|
SOHU
2144
Sohu.com
SOHU
$475M
| $241K | ﹤0.01% |
15,000
-8,400
| -36% | -$135K |
|
2145
Outlook Therapeutics
OTLK
$44M
| $240K | ﹤0.01% |
9,825
-7,680
| -44% | -$188K |
|
|
PAYA
2146
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $240K | ﹤0.01% |
39,200
+10,800
| +38% | +$66.1K |
|
2147
Larimar Therapeutics
LRMR
$350M
| $239K | ﹤0.01% |
+74,724
| New | +$239K |
|
2148
Colliers International
CIGI
$8.4B
| $238K | ﹤0.01% |
2,600
-2,100
| -45% | -$192K |
|
2149
Anterix
ATEX
$396M
| $236K | ﹤0.01% |
+6,600
| New | +$236K |
|
|
CVLY
2150
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $236K | ﹤0.01% |
12,500
-1,300
| -9% | -$24.5K |
|